Kigali, Rwanda – Rwanda has taken a significant step forward in preventive healthcare by introducing a universal hepatitis B birth dose into its national routine immunization program, a move aimed at protecting every newborn from a lifelong and potentially fatal infection.
The initiative, officially launched on January 2, 2026, ensures that all babies born in the country receive the hepatitis B vaccine within 24 hours of birth, marking a new chapter in Rwanda’s fight against viral hepatitis.
Hepatitis B is a highly infectious viral disease that can be transmitted from mother to child during childbirth. When infection occurs at birth, the consequences are severe.
Medical evidence shows that up to 95 percent of infants infected at this stage develop chronic hepatitis B, greatly increasing their risk of liver cirrhosis and liver cancer later in life.
Health experts agree that the birth dose vaccine is the most effective and cost-efficient intervention to prevent mother-to-child transmission and to stop the disease before it takes hold.
Globally, hepatitis B remains a major public health burden. An estimated 296 million people are living with chronic hepatitis B worldwide, and viral hepatitis causes more than one million deaths each year, mainly due to liver cancer and cirrhosis.
Against this backdrop, Rwanda’s decision places the country among a growing group of nations prioritizing early-life prevention as a cornerstone of disease elimination.
The introduction of the universal birth dose builds on Rwanda’s strong track record in immunization and public health delivery. National data indicate that hepatitis B prevalence in Rwanda is approximately 0.26 percent, one of the lowest rates in the region.
This success has been driven by robust vaccination systems, widespread screening programs, and free access to treatment for those diagnosed.
Health authorities say the new birth dose strengthens Rwanda’s long-term commitment to eliminating viral hepatitis as a public health threat by 2030, in line with global health targets.
To ensure smooth implementation, health facilities across the country have been fully prepared to administer the vaccine within the critical 24-hour window.
This includes provisions for babies born outside formal health facilities, reinforced cold-chain systems to maintain vaccine safety, and comprehensive training for health workers to ensure timely and accurate delivery.
These measures reflect Rwanda’s emphasis on equity and universal access, ensuring no child is left behind regardless of place of birth.
The Rwanda Biomedical Centre has called on health workers, parents, communities, and development partners to actively support the initiative by ensuring all newborns receive the hepatitis B birth dose on time.
Officials emphasize that collective responsibility is essential for the program’s success and for safeguarding future generations.
By integrating the hepatitis B birth dose into routine immunization, Rwanda reinforces its reputation as a regional leader in preventive healthcare.
The move not only protects infants from a silent but deadly virus but also advances the country’s broader vision of a healthier population and a hepatitis-free future.
